--- title: "Astellas Pharma (ALPMY.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/ALPMY.US/norm.md" symbol: "ALPMY.US" name: "Astellas Pharma" parent: "https://longbridge.com/en/quote/ALPMY.US.md" datetime: "2026-05-20T04:08:00.404Z" locales: - [en](https://longbridge.com/en/quote/ALPMY.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ALPMY.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ALPMY.US/norm.md) --- # Astellas Pharma (ALPMY.US) — Financial Reports ## Income Statement (USD) | Indicator | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | | --- | --- | --- | --- | --- | --- | | EPS | 0.2506 | 0.2558 | 0.2964 | 0.2633 | 0.2751 | | ROE | 15.73% | 16.73% | 20.48% | 18.28% | 19.93% | | Revenue | 3.47B | 3.54B | 3.53B | 3.49B | 3.07B | | Net income | 450.55M | 459.84M | 532.95M | 472.66M | 500.12M | | Operating income | 573.31M | 585.13M | 625.10M | 718.72M | 568.22M | | Gross margin | 81.24% | 81.24% | 79.87% | 81.25% | 83.27% | | Net margin | 12.97% | 12.97% | 15.11% | 13.53% | 16.31% | | Profit quality | 65.96% | 65.96% | 40.79% | 189.73% | 84.19% | ## Balance Sheet (USD) | Indicator | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 22.34B | 22.80B | 23.21B | 23.04B | 22.30B | | Leverage | 1.95 | 1.95 | 2.14 | 2.25 | 2.21 | | BVPS | 6.39 | 6.53 | 6.06 | 5.72 | 5.64 | | Turnover | 0.6195 | 0.5824 | 0.5806 | 0.5501 | 0.5536 | | Cash & STI | 1.76B | 1.80B | 1.93B | 1.49B | 1.26B | | Inv & Rec | 2.07B | 2.12B | 2.09B | 2.11B | 1.98B | | LT assets | 2.24B | 2.29B | 2.25B | 2.23B | 2.20B | | Net debt | 1.78B | 1.82B | 3.05B | 4.66B | 5.00B | ## Cash Flow Statement (USD) | Indicator | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | 869.13M | 887.05M | 1.53B | 378.82M | 674.94M | | Investing CF | -114.35M | -116.71M | -90.53M | -115.68M | -19.80M | | Financing CF | -779.59M | -795.67M | -973.86M | -76.28M | -606.40M | | Free CF | 558.13M | 627.12M | 1.32B | 93.48M | 374.99M | | OCF coverage | 97.25% | 97.25% | 242.13% | 61.31% | 124.72% | | Repaid & issued | - | - | -441.56M | 453.37M | 0.0000 | | CapEx | -98.56M | -100.59M | -90.40M | -88.48M | -64.77M | ## Distribution Plan **Dividend Yield**: 3.35 ### Dividend History | Description | Record Date | Ex-Date | Payment Date | |-------------|-------------|---------|--------------| | Cash Dividend: 0.257267USD | 2025-03-31 | 2025-03-31 | 2025-06-18 | | Cash Dividend: 0.175225USD | 2024-09-30 | 2024-09-30 | 2024-12-17 | | Cash Dividend: 0.158885USD | 2024-03-28 | 2024-03-27 | 2024-06-17 |